Clinical Trials Logo
  1. Home
  2. Alzheimer Disease, Early Onset
  3. NCT00909285

Effects of Transcranial Magnetic Stimulation (TMS) and Cognitive Training for Alzheimer Patients

Alzheimer Disease, Early Onset Clinical Trial

Official title:
Testing the Effects of TMS Stimulation and Cognitive Training for Alzheimer Patients: A Pilot Study

Clinical Trial Summary

Current diagnosis of Alzheimer disease is made by clinical, neuropsychological, and neuroimaging assessments. Routine structural neuroimaging evaluation is based on nonspecific features, such as atrophy, which is a late feature in the progression of the disease. Therefore, developing new approaches for early and specific recognition of Alzheimer disease at the prodromal stages is of crucial importance.

In the present study the investigators would like to examine if combined treatment with TMS and cognitive training (CoTra) for several weeks can produce a sustained improvement in cognitive and behavioral symptomatology of Alzheimer's disease (AD) patients. A number of in vivo neuroimaging techniques, which can be used to reliably and noninvasively assess aspects of neuroanatomy, chemistry, physiology, and pathology, hold promise.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00909285
Study type Interventional
Source Assaf-Harofeh Medical Center
Contact
Status Completed
Phase N/A
Start date July 2009
Completion date July 2010
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03625401 - Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease Phase 2
Recruiting NCT05983575 - A Pivotal Study of LIPUS-Brain in Patients With Early Alzheimer's Disease Phase 3
Completed NCT05989087 - The Resting-state EEG Gamma Oscillations in Alzheimer's Disease
Recruiting NCT06080659 - Network-based biOmarker Discovery of Neurodegenerative Diseases Using Multimodal Connectivity N/A
Not yet recruiting NCT06099587 - MIMA Pilot Study: MIcrostructure of the Medial Temporal Lobe in Early Alzheimer's Disease N/A
Not yet recruiting NCT05604183 - Hyperspectral Retinal Observations for the Cross-sectional Detection of Alzheimer's Disease N/A
Withdrawn NCT03514875 - Effects of Mitochondrial-targeted Antioxidant on Mild Cognitive Impairment (MCI) Patients N/A
Recruiting NCT06203106 - NYSCF Scientific Discovery Biobank
Completed NCT03706885 - Efavirenz for Patients With Alzheimer's Disease Phase 1
Active, not recruiting NCT03661034 - Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study) N/A
Not yet recruiting NCT05006599 - SNIFF - 3-Week Aptar CPS Device Phase 2
Recruiting NCT02740634 - Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study N/A
Active, not recruiting NCT03069391 - The Interactive Physical and Cognitive Exercise System N/A
Recruiting NCT04701957 - The Ketogenic Diet for Alzheimer's Disease N/A
Recruiting NCT06268886 - Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease Phase 2
Recruiting NCT04100889 - A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease
Recruiting NCT04656860 - Juice Plus Supplement Clinical Trial N/A
Recruiting NCT05315895 - The Dampness Syndrome of Chinese Medicine Cohort Study
Recruiting NCT04916964 - Adapted Home-based Exercise Program "T&E" (Test-and-Exercise) in Persons With Alzheimer's Disease (HOPE Trial) N/A
Recruiting NCT04804618 - Proteomics Study of Mild Cognitive Impairment and Alzheimer's Disease